• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胎盘病理学作为子痫前期后产后心血管风险筛查女性的工具:一项初步调查。

Placental Pathology as a Tool to Identify Women for Postpartum Cardiovascular Risk Screening following Preeclampsia: A Preliminary Investigation.

作者信息

Benton Samantha J, Mery Erika E, Grynspan David, Gaudet Laura M, Smith Graeme N, Bainbridge Shannon A

机构信息

Department of Health Sciences, Carleton University, Ottawa, ON K1S 5B6, Canada.

School of Interdisciplinary Health Sciences, University of Ottawa, Ottawa, ON K1H 8L1, Canada.

出版信息

J Clin Med. 2022 Mar 13;11(6):1576. doi: 10.3390/jcm11061576.

DOI:10.3390/jcm11061576
PMID:35329905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8954716/
Abstract

Preeclampsia (PE) is associated with an increased risk of cardiovascular disease (CVD) in later life. Postpartum cardiovascular risk screening could identify patients who would benefit most from early intervention and lifestyle modification. However, there are no readily available methods to identify these high-risk women. We propose that placental lesions may be useful in this regard. Here, we determine the association between placental lesions and lifetime CVD risk assessed 6 months following PE. Placentas from 85 PE women were evaluated for histopathological lesions. At 6 months postpartum, a lifetime cardiovascular risk score was calculated. Placental lesions were compared between CVD risk groups and the association was assessed using odds ratios. Multivariable logistic regression was used to develop prediction models for CVD risk with placental pathology. Placentas from high-risk women had more severe lesions of maternal vascular malperfusion (MVM) and resulted in a 3-fold increased risk of screening as high-risk for CVD (OR 3.10 (1.20-7.92)) compared to women without these lesions. MVM lesion severity was moderately predictive of high-risk screening (AUC 0.63 (0.51, 0.75); sensitivity 71.8% (54.6, 84.4); specificity 54.7% (41.5, 67.3)). When clinical parameters were added, the model's predictive performance improved (AUC 0.73 (0.62, 0.84); sensitivity 78.4% (65.4, 87.5); specificity 51.6% (34.8, 68.0)). The results suggest that placenta pathology may provide a unique modality to identify women for cardiovascular screening.

摘要

子痫前期(PE)与日后患心血管疾病(CVD)的风险增加相关。产后心血管风险筛查可以识别出那些能从早期干预和生活方式改变中获益最大的患者。然而,目前尚无现成的方法来识别这些高危女性。我们认为胎盘病变在这方面可能有用。在此,我们确定胎盘病变与子痫前期后6个月评估的终生CVD风险之间的关联。对85例PE女性的胎盘进行组织病理学病变评估。在产后6个月,计算终生心血管风险评分。比较CVD风险组之间的胎盘病变,并使用优势比评估关联。多变量逻辑回归用于建立基于胎盘病理学的CVD风险预测模型。与没有这些病变的女性相比,高危女性的胎盘有更严重的母体血管灌注不良(MVM)病变,导致筛查为CVD高危的风险增加3倍(优势比3.10(1.20 - 7.92))。MVM病变严重程度对高危筛查有中度预测性(曲线下面积0.63(0.51, 0.75);敏感性71.8%(54.6, 84.4);特异性54.7%(41.5, 67.3))。当加入临床参数时,模型的预测性能有所改善(曲线下面积0.73(0.62, 0.84);敏感性78.4%(65.4, 87.5);特异性51.6%(34.8, 68.0))。结果表明,胎盘病理学可能为识别需要进行心血管筛查的女性提供一种独特的方式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c11/8954716/d046e102ec4d/jcm-11-01576-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c11/8954716/d046e102ec4d/jcm-11-01576-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c11/8954716/d046e102ec4d/jcm-11-01576-g001.jpg

相似文献

1
Placental Pathology as a Tool to Identify Women for Postpartum Cardiovascular Risk Screening following Preeclampsia: A Preliminary Investigation.胎盘病理学作为子痫前期后产后心血管风险筛查女性的工具:一项初步调查。
J Clin Med. 2022 Mar 13;11(6):1576. doi: 10.3390/jcm11061576.
2
Placental histopathological lesions in correlation with neonatal outcome in preeclampsia with and without severe features.伴有或不伴有严重特征的子痫前期患者胎盘组织病理学病变与新生儿结局的相关性
Pregnancy Hypertens. 2018 Apr;12:6-10. doi: 10.1016/j.preghy.2018.02.001. Epub 2018 Feb 7.
3
Plasma concentrations of soluble endoglin in the maternal circulation are associated with maternal vascular malperfusion lesions in the placenta of women with preeclampsia.母体循环中可溶性内皮糖蛋白的血浆浓度与子痫前期妇女胎盘的母体血管灌注不良病变有关。
Placenta. 2019 Mar;78:29-35. doi: 10.1016/j.placenta.2019.02.014. Epub 2019 Mar 1.
4
Placental findings in non-hypertensive term pregnancies and association with future adverse pregnancy outcomes: a cohort study.非高血压足月妊娠的胎盘表现与未来不良妊娠结局的关系:一项队列研究。
Placenta. 2018 Dec 15;74:14-19. doi: 10.1016/j.placenta.2018.12.008. Epub 2018 Dec 21.
5
The association between maternal placental growth factor and placental maternal vascular malperfusion lesions.母亲胎盘生长因子与胎盘母体血管灌注不良病变之间的关联。
J Gynecol Obstet Hum Reprod. 2021 Nov;50(9):102179. doi: 10.1016/j.jogoh.2021.102179. Epub 2021 Jun 6.
6
Placental maternal vascular malperfusion and adverse pregnancy outcomes in gestational diabetes mellitus.妊娠期糖尿病患者胎盘母体血管灌注不良与不良妊娠结局
Placenta. 2017 Jan;49:10-15. doi: 10.1016/j.placenta.2016.11.004. Epub 2016 Nov 10.
7
Pathological investigation of placentas in preeclampsia (the PEARL study).子痫前期胎盘的病理学研究(PEARL研究)。
Hypertens Pregnancy. 2021 Feb;40(1):56-62. doi: 10.1080/10641955.2020.1866008. Epub 2020 Dec 29.
8
Placental morphology and the prediction of underlying cardiovascular risk factors.胎盘形态与潜在心血管危险因素的预测。
Eur J Obstet Gynecol Reprod Biol. 2021 Aug;263:56-61. doi: 10.1016/j.ejogrb.2021.05.046. Epub 2021 Jun 6.
9
Spiral artery remodeling and maternal cardiovascular risk: the spiral artery remodeling (SPAR) study.螺旋动脉重塑与孕产妇心血管风险:螺旋动脉重塑(SPAR)研究
J Hypertens. 2016 Aug;34(8):1570-7. doi: 10.1097/HJH.0000000000000964.
10
The role of placental histopathological lesions in predicting recurrence of preeclampsia.胎盘组织病理学病变在预测子痫前期复发中的作用。
Prenat Diagn. 2016 Oct;36(10):953-960. doi: 10.1002/pd.4918. Epub 2016 Sep 28.

引用本文的文献

1
Benchmarking pathology foundation models for non-neoplastic pathology in the placenta.胎盘非肿瘤性病理学的基准病理基础模型
medRxiv. 2025 Mar 20:2025.03.19.25324282. doi: 10.1101/2025.03.19.25324282.
2
Gestational Age, Infection, and Suboptimal Maternal Prepregnancy BMI Independently Associate with Placental Histopathology in a Cohort of Pregnancies without Major Maternal Comorbidities.在一组无主要母体合并症的妊娠中,孕周、感染及孕前母体BMI未达最佳状态均与胎盘组织病理学独立相关。
J Clin Med. 2024 Jun 8;13(12):3378. doi: 10.3390/jcm13123378.
3
Placental Pathology and Pregnancy Complications.

本文引用的文献

1
Maternal Vascular Lesions in the Placenta Predict Vascular Impairments a Decade After Delivery.胎盘母体血管病变可预测产后十年血管功能障碍。
Hypertension. 2022 Feb;79(2):424-434. doi: 10.1161/HYPERTENSIONAHA.121.18394. Epub 2021 Dec 9.
2
Pathological investigation of placentas in preeclampsia (the PEARL study).子痫前期胎盘的病理学研究(PEARL研究)。
Hypertens Pregnancy. 2021 Feb;40(1):56-62. doi: 10.1080/10641955.2020.1866008. Epub 2020 Dec 29.
3
Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review.
胎盘病理学与妊娠并发症
J Clin Med. 2023 Aug 1;12(15):5053. doi: 10.3390/jcm12155053.
4
Perturbations in kinetics of the thrombin generation assay identify women at risk of preeclampsia in the first trimester and provide the rationale for a preventive approach.在第一孕期中,凝血酶生成分析动力学的改变可以识别出患有先兆子痫的高风险女性,为预防性治疗提供了理论依据。
Am J Obstet Gynecol. 2023 May;228(5):580.e1-580.e17. doi: 10.1016/j.ajog.2022.11.1276. Epub 2022 Nov 8.
5
Preeclampsia at term can be classified into 2 clusters with different clinical characteristics and outcomes based on angiogenic biomarkers in maternal blood.根据母血中的血管生成生物标志物,足月子痫前期可分为具有不同临床特征和结局的 2 个亚群。
Am J Obstet Gynecol. 2023 May;228(5):569.e1-569.e24. doi: 10.1016/j.ajog.2022.11.001. Epub 2022 Nov 3.
6
Diagnostic or Therapeutic Strategies for Pregnancy Complications.妊娠并发症的诊断或治疗策略
J Clin Med. 2022 May 31;11(11):3144. doi: 10.3390/jcm11113144.
年轻女性生殖健康与晚年心血管疾病的关系:伞式综述。
BMJ. 2020 Oct 7;371:m3502. doi: 10.1136/bmj.m3502.
4
Angiogenic Factors and Long-Term Cardiovascular Risk in Women That Developed Preeclampsia During Pregnancy.妊娠期间发生子痫前期的女性的血管生成因子与长期心血管风险。
Hypertension. 2020 Dec;76(6):1808-1816. doi: 10.1161/HYPERTENSIONAHA.120.15830. Epub 2020 Oct 5.
5
Maternal risk of hypertension 7-15 years after pregnancy: clues from the placenta.妊娠 7-15 年后母亲高血压的风险:胎盘提供的线索。
BJOG. 2021 Apr;128(5):827-836. doi: 10.1111/1471-0528.16498. Epub 2020 Oct 9.
6
Contemporary clinical updates on the prevention of future cardiovascular disease in women who experience adverse pregnancy outcomes.当代临床更新:经历不良妊娠结局的女性预防未来心血管疾病。
Clin Cardiol. 2020 Jun;43(6):553-559. doi: 10.1002/clc.23374. Epub 2020 Apr 17.
7
The Placenta as a Window to Maternal Vascular Health.胎盘作为母体血管健康的窗口。
Obstet Gynecol Clin North Am. 2020 Mar;47(1):17-28. doi: 10.1016/j.ogc.2019.10.001. Epub 2019 Dec 18.
8
Causes and Consequences of the Dysregulated Maternal Renin-Angiotensin System in Preeclampsia.子痫前期母体肾素 - 血管紧张素系统失调的原因及后果
Front Endocrinol (Lausanne). 2019 Sep 10;10:563. doi: 10.3389/fendo.2019.00563. eCollection 2019.
9
Pre-eclampsia: pathophysiology and clinical implications.子痫前期:病理生理学与临床意义。
BMJ. 2019 Jul 15;366:l2381. doi: 10.1136/bmj.l2381.
10
Preeclampsia: Pathophysiology, Challenges, and Perspectives.子痫前期:病理生理学、挑战与展望。
Circ Res. 2019 Mar 29;124(7):1094-1112. doi: 10.1161/CIRCRESAHA.118.313276.